Aortic Arch Dissection clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
open to eligible people ages 18 years and up
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Sacramento, California and other locations
Our lead scientists for Aortic Arch Dissection research studies include Andrew Barleben, MD.
Last updated: